PL2822537T3 - Lek złożony do leczenia nieżytu nosa - Google Patents

Lek złożony do leczenia nieżytu nosa

Info

Publication number
PL2822537T3
PL2822537T3 PL13727040T PL13727040T PL2822537T3 PL 2822537 T3 PL2822537 T3 PL 2822537T3 PL 13727040 T PL13727040 T PL 13727040T PL 13727040 T PL13727040 T PL 13727040T PL 2822537 T3 PL2822537 T3 PL 2822537T3
Authority
PL
Poland
Prior art keywords
rhinitis
treatment
combined drug
drug
combined
Prior art date
Application number
PL13727040T
Other languages
English (en)
Inventor
Harald Greve
Original Assignee
Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48608188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2822537(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Maria Clementine Martin Klosterfrau Vertriebsges Mbh filed Critical Maria Clementine Martin Klosterfrau Vertriebsges Mbh
Publication of PL2822537T3 publication Critical patent/PL2822537T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL13727040T 2012-05-14 2013-04-16 Lek złożony do leczenia nieżytu nosa PL2822537T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102012009495 2012-05-14
DE102012011447.8A DE102012011447B4 (de) 2012-05-14 2012-05-15 Verwendung von Pantothenol oder Pantothensäure in einem Kombinationstherapeutikum für die Behandlung von Rhinitis zur Verringerung der systemischen Resorption imidazolinbasierter alpha-Sympathomimetika
EP13727040.1A EP2822537B1 (de) 2012-05-14 2013-04-16 Kombinationstherapeutikum für die behandlung von rhinitis
PCT/EP2013/001117 WO2013170921A1 (de) 2012-05-14 2013-04-16 Kombinationstherapeutikum für die behandlung von rhinitis

Publications (1)

Publication Number Publication Date
PL2822537T3 true PL2822537T3 (pl) 2016-06-30

Family

ID=48608188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13727040T PL2822537T3 (pl) 2012-05-14 2013-04-16 Lek złożony do leczenia nieżytu nosa

Country Status (9)

Country Link
EP (1) EP2822537B1 (pl)
DE (2) DE202012005650U1 (pl)
EA (1) EA030042B1 (pl)
ES (1) ES2561380T3 (pl)
GE (1) GEP20186809B (pl)
HU (1) HUE028492T2 (pl)
PL (1) PL2822537T3 (pl)
UA (1) UA111123C2 (pl)
WO (1) WO2013170921A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202012005650U1 (de) 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
DE202017104738U1 (de) * 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
WO2025093532A1 (en) * 2023-10-30 2025-05-08 Haleon Ch Sarl Pharmaceutical composition containing xylometazoline

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE10121466A1 (de) 2001-05-02 2002-11-14 Rainer Eckardt Pflege und Heilsalbe zur Behandlung trockener und entzündeter Nasenschleimhaut
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102008036725B4 (de) * 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung für die nasale Applikation
CN101756964A (zh) 2008-11-20 2010-06-30 北京利乐生制药科技有限公司 一种含有盐酸赛洛唑啉的复方药用鼻腔喷雾剂
DE202008016517U1 (de) 2008-12-12 2009-03-05 Ratiopharm Gmbh Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
DE102012005452A1 (de) 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
DE202012005650U1 (de) 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis

Also Published As

Publication number Publication date
EA201492088A1 (ru) 2015-06-30
HUE028492T2 (en) 2016-12-28
EA030042B1 (ru) 2018-06-29
DE102012011447A1 (de) 2013-11-14
WO2013170921A1 (de) 2013-11-21
EP2822537B1 (de) 2015-12-09
DE102012011447B4 (de) 2022-11-24
EP2822537A1 (de) 2015-01-14
GEP20186809B (en) 2018-01-25
UA111123C2 (uk) 2016-03-25
ES2561380T3 (es) 2016-02-25
DE202012005650U1 (de) 2013-05-15

Similar Documents

Publication Publication Date Title
IL283943A (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k related disorders
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
CY2019033I2 (el) Μακροκυκλικα παραγωγα για την αγωγη υπερπλαστικων παθησεων
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
IL243976A0 (en) kdm1a inhibitors for disease treatment
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
HUE061618T2 (hu) Vegyület szemrendellenességek kezelésére
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
EP2866826C0 (en) COMBINATION TO TREAT INFLAMMATORY DISORDERS
EP3038647A4 (en) Combination therapy for the treatment of glioblastoma
HUE056006T2 (hu) Kombináció Parkinson-kór kezelésére
IL229017B (en) Oxidative retinal diseases
PT2872497T (pt) Derivados de cromanilo para o tratamento de doenças mitocondriais
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
IL239478B (en) Prophylactic/therapeutic agent for dry eye
LT2928477T (lt) Telomerazės inhibitoriaus imetelstato panaudojimas mielofibrozės gydymui
DK3019166T3 (da) A Pharmaceutical Combination for the Treatment of Melanoma
IL231092A0 (en) Treatment of rhinitis
HUE037179T2 (hu) Gyógyászati kompozíciók izom-rendellenességek kezelésére
IL234813A0 (en) Methods for increasing efficacy of cd37-based therapy
LT2914254T (lt) Kombinacinės terapijos chemoresistencinių vėžių gydymui
IL234606B (en) Novel methods and composition for treatment of disease
DK2914310T3 (da) Medicinske indretninger med coatings til forbedret ekkogenicitet